America is embarking on a risky experiment with GLP-1s and aging

GLP-1 drugs like Wegovy are increasingly prescribed to older adults for weight loss, but clinical trials underrepresent people over 65, leaving major gaps in safety and efficacy data. Side effects such as muscle loss, dehydration, and drug interactions pose heightened risks for seniors, and functional ability—not just weight—should guide prescription decisions. The drugs require indefinite use to maintain weight loss, yet we lack long-term evidence on their effects across a full lifespan in older populations.

Teaching:
• Use the concept of functional ability over metrics: cue students to notice what practice enables them to do (play with grandkids, walk farther) rather than fixating on poses achieved or flexibility gained
• Address muscle loss and fall risk in older students by emphasizing strength-building elements of practice—chaturanga variations, chair work, standing sequence—as essential maintenance, not optional
• Frame practice as long-term maintenance therapy, not a quick fix: reinforce that benefits require sustained commitment and that stopping practice often means losing gains in mobility and stability
• Highlight heterogeneity in aging bodies: avoid one-size-fits-all adjustments for 'seniors' and instead assess each student's chronic conditions, medications, and individual capacity

Writing seeds:
• Essay on practice as indefinite-use technology: explore parallels between GLP-1s requiring lifelong adherence and Ashtanga as a maintenance system, examining what happens when practice stops and weight (physical, mental) returns
• Post contrasting weight loss metrics with functional outcomes in yoga: argue that success in practice should be measured by what students can do in daily life, not by pose achievement or body composition
• Piece on underrepresentation and individualization in yoga instruction: examine how older practitioners are often invisible in mainstream yoga marketing and teaching, and why cookie-cutter age-based modifications fail
• Short essay on cascading risks in practice: use the GLP-1 side-effect chain (dehydration to falls) as a model for understanding how one misalignment or overreach in asana can trigger downstream injuries

Idea map:
• Systems literacy: GLP-1 side effects cascade through interconnected body systems (gastric slowing to dehydration to falls); similarly, practice interventions ripple through physical, attentional, and behavioral systems
• Practice as method: just as GLP-1s are maintenance therapy requiring indefinite use, Ashtanga is a long-term method where stopping means regaining old patterns and losing functional gains
• Embodiment and heterogeneity: the article's emphasis on individualizing treatment for older adults mirrors the need to honor each student's unique body composition, chronic conditions, and life context rather than applying generic age-based cues
• Attention to functional outcomes: shifting focus from weight (a number) to what weight loss enables (walking, playing) parallels shifting yoga goals from pose achievement to what practice makes possible in daily life

Source: https://www.scientificamerican.com/article/america-is-embarking-on-a-risky-experiment-with-glp-1s-and-aging/